CAS 1803557-42-7

2-Pyridinecarboxamide, N-[(1S,2S)-2-[[3-ethyl-5-(trifluoromethyl)-2-pyrazinyl]amino]cyclopentyl]-3-(2H-1,2,3-triazol-2-yl)-

Description:

2-Pyridinecarboxamide, N-[(1S,2S)-2-[[3-ethyl-5-(trifluoromethyl)-2-pyrazinyl]amino]cyclopentyl]-3-(2H-1,2,3-triazol-2-yl)- is a complex organic compound characterized by its multi-functional structure, which includes a pyridine ring, a cyclopentyl moiety, and a triazole group. This compound is notable for its potential biological activity, often explored in medicinal chemistry for its role as a pharmaceutical agent. The presence of trifluoromethyl and ethyl groups suggests enhanced lipophilicity and potential interactions with biological targets. The stereochemistry indicated by the (1S,2S) configuration may influence its pharmacodynamics and pharmacokinetics, affecting how the compound interacts with enzymes or receptors in biological systems. Additionally, the presence of multiple heterocycles (pyridine, pyrazine, and triazole) may contribute to its reactivity and solubility properties. Overall, this compound exemplifies the complexity and diversity of modern drug design, where intricate molecular architectures are tailored for specific therapeutic applications.

Formula: C₂₀H₂₁F₃N₈O

Synonyms:

• CVN766
• 2-Pyridinecarboxamide, N-[(1S,2S)-2-[[3-ethyl-5-(trifluoromethyl)-2-pyrazinyl]amino]cyclopentyl]-3-(2H-1,2,3-triazol-2-yl)-

CVN766

CAS: 1803557-42-7

CVN766 is an orally active orexin 1 receptor antagonist with blood-brain permeability, demonstrating IC50 values of 8 nM for OX1R and >10 μM for OX2R. CVN766 can be used to study schizophrenia [1].

Formula: C₂₀H₂₁F₃N₈O

Color and Shape: Solid

Molecular weight: 446.43

Ref: TM-T86110